Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2025-10-07 Call Transcript
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an investor/analyst meeting held on October 6, 2025. It references SEBI regulations and provides a link to the audio recording of the conference call. The document does not contain the transcript itself but rather announces the availability of the recording. This fits the definition of a Call Transcript (CT) related document, but since it only provides a link to the audio recording and does not include the transcript text, it is more of an announcement related to a conference call. However, given the options, the closest and most appropriate classification is Call Transcript (CT) because the document pertains directly to the conference call content and is not merely a regulatory filing or report publication announcement. The document length is short and does not contain financial data or other report content, so it is not an Annual Report or Interim Report. Confidence is high because the document clearly relates to a conference call recording for investors and analysts.
2025-10-07 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and is explicitly described as such in the opening lines. It is addressed pursuant to SEBI regulations and is intended for an upcoming analyst/investor meeting. The content includes detailed business descriptions, strategic rationale, financial metrics, and transaction details related to an acquisition. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The document is a presentation aimed at investors, focusing on financials, strategy, and market position, consistent with the definition of an Investor Presentation (IP). The document length (11,550 characters) supports it being a full presentation rather than a brief announcement or certification. Therefore, the appropriate classification is Investor Presentation (IP).
2025-10-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the schedule of an upcoming investor/analyst conference call. It references a specific date and time for the call and provides dial-in details. The content is an announcement of a future event rather than the transcript or report of the call itself. The document length is short (2018 characters), and it does not contain any financial data or detailed discussion of results. Therefore, it is not a Call Transcript (CT) but rather a Regulatory Filing (RNS) as a general announcement under SEBI regulations about an investor meeting.
2025-10-01 English
Press Release
M&A Activity Classification · 95% confidence The document is a press release announcing the acquisition of BioPharm by Indegene Limited. It is addressed to stock exchanges and references compliance with SEBI regulations for disclosure. The content focuses on the strategic acquisition, business rationale, and company background. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is a corporate announcement about a merger and acquisition event, not a full merger filing or proxy statement. Therefore, it fits best under the category for M&A Activity announcements.
2025-10-01 English
Acquisition
M&A Activity Classification · 95% confidence The document is a formal disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the signing of a Share Purchase Agreement by the company's wholly owned subsidiary to acquire another company. It provides detailed information about the acquisition, including the target entity, consideration, and background. This type of disclosure is typical of announcements related to mergers and acquisitions. The document does not contain financial statements or detailed financial analysis but rather an announcement of a transaction. Therefore, it fits best under the category of M&A Activity (TAR). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive announcement of a transaction.
2025-10-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding the closure of the trading window for insiders due to the upcoming finalization and approval of quarterly financial results for the period ending September 30, 2025. It references SEBI regulations on insider trading and the company's internal code of conduct. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (1808 characters), and it serves as an informational notice rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-09-26 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.